Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The report covers the month of August 2025, specifically detailing a share repurchase executed on August 22, 2025. The filing is made pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Key Financial Metrics and Transaction Details
The filing details a specific share buyback transaction rather than providing comprehensive financial statements (revenue, profit, or cash flow are not included in this document).
- Transaction Date: August 22, 2025
- Shares Purchased: 243,639 ordinary shares
- Price Range: 1,479.50p (Low) to 1,498.50p (High)
- Volume-Weighted Average Price (VWAP): 1,487.66p
- Trading Venue: London Stock Exchange (XLON)
- Broker: Merrill Lynch International
- Treasury Share Holdings: 243,407,278 shares (post-transaction)
- Shares in Issue (excluding Treasury): 4,071,985,349
- Treasury Voting Rights: 5.98% of total voting rights
Material Changes and Program Status
This purchase was executed under a non-discretionary agreement entered into on June 4, 2025. Since the inception of this specific agreement on June 4, 2025, GSK has purchased an aggregate of 25,272,895 ordinary shares. The shares purchased in this transaction are held as Treasury shares. The filing confirms the updated denominator for shareholder notification calculations under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, outlook, or management commentary regarding operational performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in GSK's Annual Report on Form 20-F for 2024 and Q2 Results for 2025.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback program since June 4, 2025 (25,272,895).
- Confirm the updated percentage of voting rights held in treasury (5.98%).
- Check the total number of ordinary shares in issue excluding treasury shares (4,071,985,349) for ownership threshold calculations.
- Review the specific VWAP of 1,487.66p against market prices on August 22, 2025.